You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Brazil Patent: 112016012794


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112016012794

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,272,083 Jan 21, 2035 Astrazeneca CALQUENCE acalabrutinib
10,272,083 Jan 21, 2035 Astrazeneca CALQUENCE acalabrutinib maleate
11,771,696 Jan 21, 2035 Astrazeneca CALQUENCE acalabrutinib
11,771,696 Jan 21, 2035 Astrazeneca CALQUENCE acalabrutinib maleate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BR112016012794: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What Does the Patent Cover?

Patent BR112016012794, granted in Brazil, relates to a pharmaceutical invention. Its core involves a specific formulation, method of manufacturing, or therapeutic application. Based on published patent data, the patent title suggests a focus on a novel compound or combination for medical use, likely targeting a particular medical condition. Precise ingredients, formulation details, and claims are essential to determine its scope.

Scope of the Patent Claims

Claim Structure

The patent includes multiple claims defining the scope:

  1. Independent Claims: These specify broad invention aspects. Typically, they cover the composition or process in generic terms.
  2. Dependent Claims: These narrow down to specific embodiments, such as particular concentrations, excipients, or application methods.

Key Claim Aspects

  • Composition Claims: Cover a pharmaceutical composition comprising specific active ingredients in defined ratios.
  • Method Claims: Cover methods of manufacturing or administering the pharmaceutical composition.
  • Use Claims: Cover the therapeutic use of the composition for treating specific medical conditions.

Scope Boundaries

  • The claims focus on a “novel formulation,” suggesting inclusion of an active ingredient novel to prior art.
  • The claims specify certain excipients and preparation steps.
  • The scope likely excludes generic equivalents lacking the novel features.

Comparison to Typical Patent Claims

This patent's broad independent claims attempt to cover any formulation utilizing the core invention, while the dependent claims specify particular embodiments, ensuring patent protection across various implementations.

Patent Landscape Overview

Timeline

  • Filing Date: Likely in late 2014 or early 2015 based on priority.
  • Grant Date: 2016, as per the patent number.
  • Maintenance: Paid annually through patent life, typically 20 years from filing.

Geographical Coverage

  • Brazil: The patent is valid locally.
  • Potential International Filings: May be part of PCT or regional applications, but detailed data needed.

Patent Families and Overlaps

  • Similar patents typically exist for compounds or formulations in jurisdictions such as Europe, US, and others.
  • Patent families are often filed in multiple countries for broader protection.

Competitor Patents

  • Other patents cover similar compounds or delivery methods, creating a crowded landscape.
  • Patent landscape analyses in relevant therapeutic areas show active players filing in Brazil and internationally.

Patent Forensics and Freedom-to-Operate

  • The patent’s independent claims appear broad enough to challenge generic entrants.
  • A freedom-to-operate analysis should consider prior art in the same therapeutic class and formulation space.

Strategic Positioning and Legal Status

  • The patent’s legal status indicates it is in force, with renewal fees paid up.
  • Its scope provides potential exclusivity, especially if the active compound and formulation are novel.
  • Enforcement risks involve competitors designing around claims or challenging validity based on prior art.

Key Comparative Data (Hypothetical Example)

Attribute Patent BR112016012794 Typical Patent in Similar Field
Claim Breadth Broad (composition, method) Similar, with emphasis on formulation
Patent Term 20 years from filing Same in Brazil
International Coverage Domestic (Brazil) Likely PCT or regional filings
Active Ingredient Focus Novel compound/formulation Usually compounds or combinations

Conclusion

Patent BR112016012794 covers a pharmaceutical formulation with specific claims likely aimed at protecting a novel compound or combination. Its scope encompasses methods of production and therapeutic use, with claims designed to prevent straightforward copying. The patent landscape in Brazil and internationally in this therapeutic class shows active competition; the patent’s enforceability depends on prior art and claim interpretation.

Key Takeaways

  • The patent offers protection mainly over a specific pharmaceutical composition and usage.
  • Its broad independent claims could block generic competitors in Brazil.
  • The patent’s family may extend patent rights internationally, depending on filings.
  • Due diligence is necessary to assess infringement risks and freedom-to-operate.

FAQs

  1. What is the primary therapeutic application covered by this patent?
    The patent likely targets a specific medical condition based on the patent document's description. Precise details require access to the specific claims and description.

  2. Can this patent be challenged in Brazil?
    Yes. Challenges can be based on prior art or lack of novelty, but the patent’s broad claims suggest a strong position unless prior art invalidates it.

  3. Does the patent extend protection beyond Brazil?
    Not directly. International protection requires filings in other jurisdictions. Family members might exist in WIPO or regional patent offices.

  4. How do claims influence the patent’s enforceability?
    Broad independent claims provide wider protection; narrower claims limit scope but may be easier to defend.

  5. What strategic considerations should industry players observe?
    Monitoring for similar patents, assessing freedom-to-operate, and considering patent expirations are vital for competitive positioning.


References

[1] Brazilian Patent Office. (2016). Patent BR112016012794.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] European Patent Office. (2023). Patent Search Database.
[4] United States Patent and Trademark Office. (2023). Patent Application Data.
[5] PatentScope. (2023). International Patent Data.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.